Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by Bigcity1on Feb 01, 2017 11:22am

80 Views

Post# 25783331

inmed (IN)

Hey All...... I am a big advocate for NF and hold many shares. I do have a favor to ask the kind people of this board.

Just wondering if any would like to share level 2 for Inmed (IN) for me.

I do understand there is a board for IN however i am unable to find anyone to help

Thank you to all and good luck on the NF. I recently saw a MJ reit open on the NYSE at 19 dollars. Now i dont think we have near enough for that yet however there is a business model out there that has proven that this works.

Cheers,

Bullboard Posts

Canadian artificial intelligence ETFs